The main treatment target, which should be based on a shared decision with the patient, was defined as remission, with the alternative target of low disease activity.
The main risk during treatment, which involves several bouts of chemotherapy, is infection and Petrov will have to spend periods in isolation.
On the other hand, we have to point out that this route is, in some cases, associated with a passive cell entrapment within tissues that do not represent the main target of treatment, which may potentially lead to unwanted effects and may be eventually associated to a reduced effect of the cells.
Finally, the in vitro study does not assess the effect of sunitinib on the tumour vasculature [28], the main target of this treatment, which is a limitation of the epithelial cell culture used in this study.
The main treatment is surgery, which consisted of a cystoprostatectomy with a pelvic lymphadenectomy in all reported cases, except ours where vesiculo-prostatectomy was done without cystectomy and without any local relapse during the follow-up.
Open fractures of the tibial diaphysis are managed by four main approaches: (1) non-operative treatment, which includes a full-length plaster cast, a hinged brace allowing knee movement or functional braces that allow knee and foot movement; the other approaches involve surgical stabilisation which include: (2) plates; (3) intramedullary nailing (IMN); or (4) external fixation (EF).
Another worry is about the "reference-cost" figures for various types of treatment, which are the main new source for the revised output series.
The main harm from overdiagnosis is unnecessary treatment, which in the case of pulmonary embolism means anticoagulation a leading cause of medication related death.
The prevalence of osteoporosis can have a significant effect on the cut-off value for the BMD test and treatment, which were the main elements in the guidelines for osteoporosis.
As already mentioned earlier, singular AR models have led to new challenges in econometric time series modeling, and they deserve and require a special treatment, which is the main task of this paper.
(26, 31, 32) Although 44% of patients were already taking antihypertensive medications prior to study entry, over 50% of patients developed hypertension after one cycle of axitinib treatment, which was the main reason for axitinib dose reductions or temporary dose interruptions.
